Pediatric AML

The Prognostic Significance of Incomplete Hematological Recovery in Pediatric AML Patients with Negative MRD Following Induction Therapy
Evaluation of the Clinical Outcomes Among the Pediatric Low-risk Acute Myeloid Leukemia Patients Who Received Four Versus Five Cycles of Chemotherapy: Single-center Study
Response of Relapsed/ Refractory Pediatric AML to Clad-AraC